Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

An MIT-developed system uses microbes for manufacturing small amounts of vaccines and other therapies.

Portable Device Delivers Biopharmaceuticals on Demand

Fintan Weston is manufacturing director at Symbiosis Pharmaceutical Services.

While isolators may offer advantages in high-speed commercial manufacturing lines, RABS continues to be a flexible alternative solution for small-scale production of drugs for clinical use.

Debating the Role of RABS and Isolators in Aseptic Manufacturing

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Amgen discussed the drug-delivery approaches to two of its biologics in a recent second-quarter earnings call.

Amgen: Neulasta Safe for Now; Dose Accuracy of Erenumab a New Focus

NIST’s monoclonal antibody reference material can be used as a standard for biopharmaceutical analytical quality control.

NIST Issues mAb Reference Standard

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA and industry seek speedy Congressional approval of new user fee plan.

The Industry Hopes Congress Approves PDUFA Program in 2016

The Phase I trial will test Bavarian Nordic’s vaccine, which is manufactured using a vaccine vector based on smallpox.The recent resurgence of yellow fever incidences over the past six months has prompted health officials to ramp up the fight against the virus. Like the Zika virus, yellow fever is transmitted primarily through the bite of infected female Aedes aegypti mosquitoes.

NIH-Backed Yellow Fever Vaccine Trial Announced

The affinity purification company will set up shop at the former Merck & Co./GlycoFi facility in the Dartmouth Regional Technology Center in New Hampshire.

Avitide Plants Flag at Former Merck Location

The project involves installation of a small-scale pressured agitated nutsche filter dryer in glass, integrated in a high-containment isolator to achieve an occupational exposure limit of less than 1 microgram per meter cube, 8-hour time weighted average.

Powder Systems Limited Installs High-Containment Filter Dryer in Australian API Manufacturing Plant

The vaccine candidate has also won a Priority Medicines (PRIME) status from EMA.

Merck Receives Breakthrough Therapy Designation for Ebola Vaccine

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Gamma-stable fluoropolymers are an alternative material for single-use bags and assemblies in biopharmaceutical manufacturing.